SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sam who wrote (359)10/30/1997 6:50:00 PM
From: DZOO  Read Replies (2) of 834
 
Thanks for the post. One thing that got my curiosity up. He states that there is a possible 1 billion dollar market for their phase II drug. He states that the stock price could easily double. Those two statements put together don't make sense to me. If they get FDA approval for their lead compound and the market for that compound is indeed 1 billion dollars then I would think their stock would do a heck of alot more than double. Look at IDPH for example. Comments welcome!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News